Female, n (%) |
137 (79.2) |
64 (82.1) |
73 (76.8) |
0.401 |
Age, years |
54.87 ± 8.77 |
52.50 ± 8.89 |
56.81 ± 8.22 |
0.001 |
Body mass index, kg/cm2
|
22.49 ± 2.98 |
22.16 ± 2.88 |
22.76 ± 3.05 |
0.189 |
Risk factors |
|
|
|
|
Hypertension, n (%) |
35 (20.2) |
10 (12.8) |
25 (26.3) |
0.036 |
Diabetes mellitus, n (%) |
13 (7.5) |
3 (3.8) |
10 (10.5) |
0.097 |
Previous rheumatic heart valve disease, n (%) |
168 (97.1) |
76 (97.4) |
92 (96.8) |
>0.999 |
Creatinine, µmol/L |
64.0 (56.0–79.9) |
64.0 (56.9–82.0) |
64.0
(55.6–77.3) |
0.739 |
Albumin, g/L |
38.65 ± 5.64 |
38.81 ± 6.50 |
38.51 ± 4.86 |
0.732 |
Atrial fibrillation/flutter, n (%) |
168 (97.1) |
75 (96.2) |
93 (97.9) |
0.407 |
Pulmonary artery systolic pressure ≥ 60 mmHg, n (%) |
10 (5.8) |
6
(7.7) |
4 (4.2) |
0.349 |
NYHA class ≥ III, n (%) |
96 (55.5) |
54 (69.2) |
42 (44.2) |
0.001 |
NYHA class IV, n (%) |
16 (9.2) |
11 (14.1) |
5 (5.3) |
0.046 |
Echocardiography |
|
|
|
|
RAD, mm |
82.24 ± 17.78 |
84.74 ± 18.49 |
80.19 ± 17.01 |
0.094 |
RVED, mm |
60.48 ± 8.57 |
60.32 ± 9.07 |
60.61 ± 8.19 |
0.827 |
LVEF, % |
61.94 ± 6.55 |
61.70 ± 6.63 |
62.14 ± 6.52 |
0.666 |
Systolic pulmonary artery pressure, mmHg |
41.0 (36.0–48.0) |
41.0
(36.0–48.0) |
40.0 (35.0–48.0) |
0.564 |
Jet area of tricuspid regurgitation, cm2
|
21.0
(16.0–27.6) |
23.4 (15.9–30.3) |
20.0 (16.0–26.5) |
0.215 |
Previous cardiac surgery, n (%) |
|
|
|
|
DVR |
47 (27.2) |
19 (24.4) |
28 (29.5) |
0.452 |
DVR + TVr |
24 (13.9) |
9 (11.50 |
15 (15.8) |
0.421 |
MVR |
77 (44.5) |
37 (47.4) |
40 (42.1) |
0.483 |
MVR + TVr |
22 (12.7) |
12 (15.4) |
10 (10.5) |
0.340 |
AVR |
1 (0.6) |
0 (0) |
1 (1.1) |
>0.999 |
MVR + AVr + TVr |
1 (0.6) |
1 (1.3) |
0 (0) |
0.451 |
Bentall’s surgery |
1 (0.6) |
0 (0) |
1 (1.1) |
>0.999 |
Interval from last heart operation, years |
14.0 (10.0–20.0) |
11.0
(8.8–17.0) |
16.0 (11.0–22.0) |
<0.001 |